NDC 10019-956-16 - Cyclophosphamide

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 10019-956
Requested NDC: 10019-956-16
Package NDCs from labels: 10019-956-16, 10019-956-01
Manufacturer: Baxter Healthcare Company | Baxter Healthcare Corporation
Effective date: 2025-06-24
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Cyclophosphamide - Baxter Healthcare Company \| Baxter Healthcare Corporation	Baxter Healthcare Company \| Baxter Healthcare Corporation	2025-06-24	HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unit	National Council for Prescription Drug Programs	2013-02-13	Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10019-956-01	Cyclophosphamide	1 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	1		20
10019-956-16	Cyclophosphamide	50 mL in 1 VIAL, SINGLE-DOSE	INJECTION, POWDER, FOR SOLUTION	50		20

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10019-956	CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]	17	Current NDC, Legacy NDC, 2 package rows	20250114_591d9955-3d9c-4cdc-a308-2f1288376b9f.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
10019-956-01	EA - Each	10019-956	e681db4f-441b-417d-af92-5cf7308a2d2b	1	2012-07-24
10019-956-16	EA - Each	10019-956	02bad1bb-9755-4024-bc66-0ac183cc6075	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version	Uploaded
CYCLOPHOSPHAMIDE	ACTIVE INGREDIENT	8N3DW7272P	CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]	5
CYCLOPHOSPHAMIDE ANHYDROUS	ACTIVE MOIETY	6UXW23996M	CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]	5

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 29 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cyclophosphamide	CYCLOPHOSPHAMIDE	Nexus Pharmaceuticals, LLC	c961a1ac-6705-4756-9abc-9d84a6fcb5c8	2026-09-03	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
Frindovyx	CYCLOPHOSPHAMIDE	AVYXA Pharma, LLC	5ad8ea65-4c98-487a-9c8d-df778765ec5e	2026-08-26	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	BluePoint Laboratories	1d3396d8-4c03-4a28-890a-d87c6c53a74e	2026-03-12	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	BluePoint Laboratories	d7e97b99-83db-42d0-8521-b87fe6467a67	2026-02-12	Warnings, Adverse reactions	Exact identifier application number: ANDA040745 rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Avenacy, LLC	1de02105-9c5b-4d11-bddf-bf8450d88b78	2026-02-01	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Amneal Pharmaceuticals LLC	520bfe39-dfd5-4a20-9a37-80078afded0d	2026-01-19	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	Bamboo US Bidco LCC	2873b99a-830d-0a7b-e063-6394a90a4de7	2025-12-03	Warnings, Adverse reactions	Exact identifier application number: ANDA040745 rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Epic Pharma, LLC	988d2f71-1dc7-45b5-b2df-187e68224973	2025-11-17	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Civica, Inc.	8627c83f-c057-495d-9f78-8b67bda97b3e	2025-10-24	Warnings, Adverse reactions	Exact identifier application number: ANDA040745 rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Baxter Healthcare Company	591d9955-3d9c-4cdc-a308-2f1288376b9f	2025-06-24	Warnings, Adverse reactions	Exact identifier application number: ANDA040745 ndc (package): 10019-957-11 ndc (package): 10019-956-16 ndc (package): 10019-955-01 ndc (package): 10019-956-01 ndc (package): 10019-957-01 ndc (package): 10019-955-50 ndc (product): 10019-955 ndc (product): 10019-957 ndc (product): 10019-956 ndc11 (package): 10019095616 rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 spl id: a466e63c-d425-4387-a41f-d1cd8023f694 spl set id: 591d9955-3d9c-4cdc-a308-2f1288376b9f unii: 8N3DW7272P
CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	Baxter Healthcare Company	97ab446f-5017-4180-ae65-0a355289b0ed	2025-06-20	Warnings, Adverse reactions	Exact identifier application number: ANDA040745 rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Eugia US LLC	3c1eb470-0bba-457d-94e3-b9508f0d398a	2025-04-21	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE FOR INJECTION	Slate Run Pharmaceuticals, LLC	20bda486-cb9a-4d67-8c41-50e9fd066434	2025-04-02	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Sandoz Inc.	0e9e22fa-178a-42fc-9f82-c303db3b245a	2025-03-05	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Sagent Pharmaceuticals	329b5a3a-c7b9-4b11-abf0-009719cdfb79	2025-01-22	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Cipla USA Inc.	0e1cb955-99c8-4fe5-89d1-399c8e52174e	2025-01-10	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE FOR INJECTION	Hainan Poly Pharm. Co., Ltd.	6fde2705-a2d8-4d48-9618-b9d99d051373	2025-01-03	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Sandoz Inc	cf2f4b95-0327-499a-a5a3-51b1bdef68c5	2024-12-30	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	XGen Pharmaceuticals DJB, Inc.	02e64046-687d-449e-e063-6294a90a6c32	2024-12-20	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Alembic Pharmaceuticals Limited	9e699cf7-860e-4c03-9760-0c24d56df2de	2024-12-16	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.